-
Je něco špatně v tomto záznamu ?
Penetration, distribution and brain toxicity of titanium nanoparticles in rodents' body: a review
T. Zeman, EW. Loh, D. Čierný, O. Šerý,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
- MeSH
- biologický transport MeSH
- hlodavci MeSH
- kovové nanočástice * toxicita MeSH
- mozek účinky léků metabolismus MeSH
- nanočástice toxicita MeSH
- neurotoxické syndromy * metabolismus patologie veterinární MeSH
- reaktivní formy kyslíku metabolismus MeSH
- titan farmakokinetika toxicita MeSH
- tkáňová distribuce MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Titanium dioxide (TiO2) has been vastly used commercially, especially as white pigment in paints, colorants, plastics, coatings, cosmetics. Certain industrial uses TiO2 in diameter <100 nm. There are three common exposure routes for TiO2: (i) inhalation exposure, (ii) exposure via gastrointestinal tract, (iii) dermal exposure. Inhalation and gastrointestinal exposure appear to be the most probable ways of exposure, although nanoparticle (NP) penetration is limited. However, the penetration rate may increase substantially when the tissue is impaired. When TiO2 NPs migrate into the circulatory system, they can be distributed into all tissues including brain. In brain, TiO2 lead to oxidative stress mediated by the microglia phagocytic cells which respond to TiO2 NPs by the production and release of superoxide radicals that convert to multiple reactive oxygen species (ROS). The ROS production may also cause the damage of blood-brain barrier which then becomes more permeable for NPs. Moreover, several studies have showed neuron degradation and the impairment of spatial recognition memory and learning abilities in laboratory rodent exposed to TiO2 NPs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045305
- 003
- CZ-PrNML
- 005
- 20200114144333.0
- 007
- ta
- 008
- 200109s2018 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1049/iet-nbt.2017.0109 $2 doi
- 035 __
- $a (PubMed)30104440
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Zeman, Tomáš $u Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic.
- 245 10
- $a Penetration, distribution and brain toxicity of titanium nanoparticles in rodents' body: a review / $c T. Zeman, EW. Loh, D. Čierný, O. Šerý,
- 520 9_
- $a Titanium dioxide (TiO2) has been vastly used commercially, especially as white pigment in paints, colorants, plastics, coatings, cosmetics. Certain industrial uses TiO2 in diameter <100 nm. There are three common exposure routes for TiO2: (i) inhalation exposure, (ii) exposure via gastrointestinal tract, (iii) dermal exposure. Inhalation and gastrointestinal exposure appear to be the most probable ways of exposure, although nanoparticle (NP) penetration is limited. However, the penetration rate may increase substantially when the tissue is impaired. When TiO2 NPs migrate into the circulatory system, they can be distributed into all tissues including brain. In brain, TiO2 lead to oxidative stress mediated by the microglia phagocytic cells which respond to TiO2 NPs by the production and release of superoxide radicals that convert to multiple reactive oxygen species (ROS). The ROS production may also cause the damage of blood-brain barrier which then becomes more permeable for NPs. Moreover, several studies have showed neuron degradation and the impairment of spatial recognition memory and learning abilities in laboratory rodent exposed to TiO2 NPs.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologický transport $7 D001692
- 650 _2
- $a mozek $x účinky léků $x metabolismus $7 D001921
- 650 12
- $a kovové nanočástice $x toxicita $7 D053768
- 650 _2
- $a nanočástice $x toxicita $7 D053758
- 650 12
- $a neurotoxické syndromy $x metabolismus $x patologie $x veterinární $7 D020258
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a hlodavci $7 D012377
- 650 _2
- $a tkáňová distribuce $7 D014018
- 650 _2
- $a titan $x farmakokinetika $x toxicita $7 D014025
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Loh, El-Wui $u Center for Evidence - based Health Care, Taipei Medical University - Shuang Ho Hospital, No. 291, Zhongzheng Road, Zhonghe District, New Taipei City 23561, Taiwan.
- 700 1_
- $a Čierný, Daniel $u Department of Clinical Biochemistry, Jessenius Faculty of Medicine in Martin, Kollárova 2, 03659 Martin, Slovak Republic.
- 700 1_
- $a Šerý, Omar $u Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Veveří 97, 602 00 Brno, Czech Republic. omarsery@sci.muni.cz.
- 773 0_
- $w MED00189529 $t IET nanobiotechnology $x 1751-8741 $g Roč. 12, č. 6 (2018), s. 695-700
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30104440 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200114144705 $b ABA008
- 999 __
- $a ok $b bmc $g 1483574 $s 1083978
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 12 $c 6 $d 695-700 $e - $i 1751-8741 $m IET nanobiotechnology $n IET Nanobiotechnol $x MED00189529
- LZP __
- $a Pubmed-20200109